Development of a drug-eluting 3D bioprinted mesh (GlioMesh) for treatment of glioblastoma multiforme
Glioblastoma multiforme (GBM) is among the most aggressive and mortal cancers of the central nervous system. Maximal safe surgical resection, followed by radiotherapy accompanied with chemotherapy is the standard of care for GBM patients. Despite this intensive treatment with conventional approaches...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | English en |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://dspace.library.uvic.ca//handle/1828/9305 |